bearish
Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)
660 Views03 Dec 2018 10:11
Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Junshi Bio (君实医药) Placement - Expected Deal but Large Deal Size15 Jun 2021
- Junshi Bioscience Lock-Up Expiry: Valuation Still Rich with Few R&D Updates24 Jun 2019
- Junshi Bioscience (君实医药) IPO: Rich Valuation, but Catalyst Ahead11 Dec 2018
- Junshi Bioscience (君实医药) IPO: Early in Application but Behind in Key Indications (Part 1)12 Nov 2018
- Innovent Biologics (信达生物) IPO: Pricing the PD-1 and Biosimilars Competition (Part 2)10 Oct 2018
x